vincenzo Cerullo
Helsingin yliopisto
H-index: 45
Europe-Finland
Top articles of vincenzo Cerullo
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy
Molecular Therapy Oncology
2024/3/21
Salvatore Russo
H-Index: 16
Jacopo Chiaro
H-Index: 3
Lucio Pastore
H-Index: 19
Vincenzo Cerullo
H-Index: 28
Translational Aspects of Epithelioid Sarcoma: Current Consensus
2024/3/15
Vincenzo Cerullo
H-Index: 28
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines
International Journal of Biological Macromolecules
2024/3/1
Usos de um vetor adenoviral oncolítico que codifica pelo menos uma citocina, e uma composição terapêutica de célula adotiva separada, kit farmacêutico, vetores adenovirais …
2024/2/27
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation
Heliyon
2024/2/15
Bruno Catalanotti
H-Index: 14
Lucio Pastore
H-Index: 19
Vincenzo Cerullo
H-Index: 28
Gennaro Piccialli
H-Index: 18
Nicola Borbone
H-Index: 19
Using an oncolytic virus with an immune checkpoint inhibitor to improve mesothelioma treatment
2024/2/13
Dariusz Plewczynski
H-Index: 23
Vincenzo Cerullo
H-Index: 28
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors
Journal for ImmunoTherapy of Cancer
2024
Salvatore Russo
H-Index: 16
Jacopo Chiaro
H-Index: 3
Jeanette Leusen
H-Index: 27
Vincenzo Cerullo
H-Index: 28
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses
Molecular Therapy-Oncolytics
2023/3/16
Salvatore Russo
H-Index: 16
Jacopo Chiaro
H-Index: 3
Francesca Greco
H-Index: 7
Jeanette Leusen
H-Index: 27
Vincenzo Cerullo
H-Index: 28
Modified adenoviruses for infectious disease vaccine development
2023/3/2
Systems biology approaches for the improvement of oncolytic virus-based immunotherapies
2023/2/17
Lucio Pastore
H-Index: 19
Vincenzo Cerullo
H-Index: 28
Cancer immunotherapies: A hope for the uncurable?
2023/2/17
Vincenzo Cerullo
H-Index: 28
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting
Frontiers in Immunology
2023/2/3
Characterization of expanded gamma delta T cells from atypical X-SCID patient reveals preserved function and IL2RG-mediated signaling
Journal of clinical immunology
2023/2
Markku Varjosalo
H-Index: 29
Vincenzo Cerullo
H-Index: 28
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell …
Frontiers in oncology
2023
Dariusz Plewczynski
H-Index: 23
Vincenzo Cerullo
H-Index: 28
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR
Science Advances
2023/12/1
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors
Nature Communications
2023/11/3
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma
Iscience
2023/10/20
Thomas Whalley
H-Index: 2
Giuseppe Castaldo
H-Index: 9
Vincenzo Cerullo
H-Index: 28
Lucio Pastore
H-Index: 19
Modified mycobacterium bovis vaccines
2023/10/12
Recent highlights in molecular medicine
2023/10/4
Vincenzo Cerullo
H-Index: 28
Giorgio Stassi
H-Index: 47
Personalizing oncolytic virotherapy
2023/9/1
Vincenzo Cerullo
H-Index: 28
Co-Authors
